JP2005533809A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533809A5
JP2005533809A5 JP2004515897A JP2004515897A JP2005533809A5 JP 2005533809 A5 JP2005533809 A5 JP 2005533809A5 JP 2004515897 A JP2004515897 A JP 2004515897A JP 2004515897 A JP2004515897 A JP 2004515897A JP 2005533809 A5 JP2005533809 A5 JP 2005533809A5
Authority
JP
Japan
Prior art keywords
substituted
compound
disease
unsubstituted
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004515897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533809A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/019245 external-priority patent/WO2004000807A1/en
Publication of JP2005533809A publication Critical patent/JP2005533809A/ja
Publication of JP2005533809A5 publication Critical patent/JP2005533809A5/ja
Pending legal-status Critical Current

Links

JP2004515897A 2002-06-19 2003-06-17 カンナビノイドレセプタアゴニスト Pending JP2005533809A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38978802P 2002-06-19 2002-06-19
PCT/US2003/019245 WO2004000807A1 (en) 2002-06-19 2003-06-17 Cannabinoid receptor agonists

Publications (2)

Publication Number Publication Date
JP2005533809A JP2005533809A (ja) 2005-11-10
JP2005533809A5 true JP2005533809A5 (enExample) 2006-07-06

Family

ID=30000466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004515897A Pending JP2005533809A (ja) 2002-06-19 2003-06-17 カンナビノイドレセプタアゴニスト

Country Status (14)

Country Link
US (1) US7217732B2 (enExample)
EP (1) EP1539693B9 (enExample)
JP (1) JP2005533809A (enExample)
CN (1) CN1662496A (enExample)
AR (1) AR039698A1 (enExample)
AT (1) ATE388937T1 (enExample)
AU (1) AU2003243637A1 (enExample)
CA (1) CA2487346A1 (enExample)
DE (1) DE60319714T2 (enExample)
ES (1) ES2303599T3 (enExample)
MX (1) MXPA04012704A (enExample)
PE (1) PE20040574A1 (enExample)
TW (1) TW200405892A (enExample)
WO (1) WO2004000807A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067539B2 (en) * 2001-02-08 2006-06-27 Schering Corporation Cannabinoid receptor ligands
US7868204B2 (en) * 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
US6897220B2 (en) * 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
KR20100107509A (ko) * 2001-09-14 2010-10-05 9222-9129 퀘벡 인코포레이티드 히스톤 데아세틸라아제의 억제제
UY27939A1 (es) 2002-08-21 2004-03-31 Glaxo Group Ltd Compuestos
WO2004113320A1 (en) * 2003-05-20 2004-12-29 The University Of Tennessee Research Foundation Cannabinoid derivatives, methods of making, and use thereof
WO2005016351A1 (ja) * 2003-08-18 2005-02-24 Shionogi & Co., Ltd. カンナビノイド受容体アゴニストの新規用途
US20070032483A1 (en) * 2003-09-11 2007-02-08 Julia Greil Process for the production of mycophenolate mofetil
EP1663953A1 (en) * 2003-09-24 2006-06-07 Methylgene, Inc. Inhibitors of histone deacetylase
PT1701940E (pt) * 2003-12-23 2008-07-30 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-benzil-amina como ssri
GB0402355D0 (en) * 2004-02-03 2004-03-10 Glaxo Group Ltd Novel compounds
US7253204B2 (en) * 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
EP1763346A4 (en) * 2004-05-21 2009-03-04 Uab Research Foundation COMPOSITIONS AND METHODS RELATED TO PYRIMIDINE SYNTHESIS
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
US7629473B2 (en) * 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
PE20080197A1 (es) * 2006-02-09 2008-04-11 Schering Corp Combinaciones que involucran el (los) inhibidor (es) de la proteasa del hcv, y metodos de tratamiento relacionado al (los) mismos(s)
CN101466670B (zh) * 2006-04-07 2013-04-17 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
CA2657247A1 (en) 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US7928123B2 (en) 2006-09-25 2011-04-19 Boehringer Ingelheim International Gmbh Compounds which modulate the CB2 receptor
CA2679185A1 (en) 2007-02-28 2008-09-04 Advinus Therapeutics Private Limited 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
CA2704684A1 (en) 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
WO2010005782A1 (en) 2008-07-10 2010-01-14 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the cb2 receptor
PE20110397A1 (es) 2008-09-25 2011-07-01 Boehringer Ingelheim Int Compuestos que modulan selectivamente el receptor cb2
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
JP2013505295A (ja) 2009-09-22 2013-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を選択的に調節する化合物
WO2011088015A1 (en) 2010-01-15 2011-07-21 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
AU2011265047B2 (en) 2010-06-07 2014-10-23 Novomedix, Llc Furanyl compounds and the use thereof
WO2012012307A1 (en) 2010-07-22 2012-01-26 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 rece
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
US9636298B2 (en) 2014-01-17 2017-05-02 Methylgene Inc. Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
CN112552200B (zh) * 2019-09-10 2024-03-12 烟台药物研究所 一种光学纯4-(1-氨基)乙基苯甲酸酯及其盐的制备方法
CN111909053B (zh) * 2020-08-06 2022-12-06 湖北省生物农药工程研究中心 基于二芳胺单元的酰胺类衍生物及其制备方法和应用

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2419199A (en) * 1945-02-09 1947-04-22 Parke Davis & Co Quinoline compounds and process of making same
JPS5630893A (en) * 1979-08-24 1981-03-28 Sumitomo Chem Co Ltd Recording paper
US4466965A (en) 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US4567184A (en) 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
NO174506B (no) 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
JPH0625159B2 (ja) * 1987-09-10 1994-04-06 宇部興産株式会社 アラルキルアミノピリミジン誘導体、その製造法並びに該誘導体を有効成分とする殺虫剤、殺ダニ剤及び殺菌剤
JPH0647578B2 (ja) * 1986-10-08 1994-06-22 宇部興産株式会社 アラルキルアミノピリミジン誘導体、その製造法並びに該誘導体を有効成分とする殺虫剤、殺ダニ剤及び殺菌剤
DE3766475D1 (de) 1986-11-03 1991-01-10 Merck & Co Inc 4-(benzoyl)thiophen(oder furan)-sulfonamid und derivate fuer die aeusserliche behandlung von erhoehtem augeninnendruck.
JP2531989B2 (ja) * 1988-09-14 1996-09-04 吉富製薬株式会社 ピリジン化合物
JP2861104B2 (ja) * 1988-10-14 1999-02-24 三菱化学株式会社 ピラゾールアミド類およびこれを有効成分とする殺虫、殺ダニ剤
US5064825A (en) 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
WO1991000858A1 (en) 1989-07-07 1991-01-24 Schering Corporation Pharmaceutically active compounds
US5332820A (en) 1991-05-20 1994-07-26 E. I. Du Pont De Nemours And Company Dibenzobicyclo(2.2.2) octane angiotensin II antagonists
US5506227A (en) 1992-04-13 1996-04-09 Merck Frosst Canada, Inc. Pyridine-substituted benzyl alcohols as leukotriene antagonists
JPH0672979A (ja) 1992-06-08 1994-03-15 Hiroyoshi Hidaka アミノベンジル誘導体
US5338753A (en) 1992-07-14 1994-08-16 Sumner H. Burstein (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics
AU4949293A (en) * 1992-08-28 1994-03-29 Ciba-Geigy Ag Indazole derivatives
US5486525A (en) 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
FR2714057B1 (fr) 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
US5596106A (en) * 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
IT1271266B (it) 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
NZ301265A (en) 1995-02-02 1998-12-23 Smithkline Beecham Plc Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof
US5532237A (en) * 1995-02-15 1996-07-02 Merck Frosst Canada, Inc. Indole derivatives with affinity for the cannabinoid receptor
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
FR2735774B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
JPH11510485A (ja) 1995-07-21 1999-09-14 ニィコメド・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 酵素のシクロオキシゲナーゼｉｉの阻害剤としてのベンゼンスルホンアミドの誘導体
DE19533644A1 (de) 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue Benzolsulfonamide
FR2742148B1 (fr) 1995-12-08 1999-10-22 Sanofi Sa Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
AU1618697A (en) 1996-02-06 1997-08-28 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
JP2001500864A (ja) 1996-09-13 2001-01-23 メルク エンド カンパニー インコーポレーテッド トロンビン阻害物質
ES2213892T3 (es) 1997-01-21 2004-09-01 Smithkline Beecham Corporation Nuevos moduladores del receptor de canabinoides.
ATA16597A (de) 1997-02-03 1998-04-15 Nycomed Austria Gmbh Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide
EP0979228A4 (en) 1997-03-18 2000-05-03 Smithkline Beecham Corp CANNABINOID RECEPTOR AGONISTS
DE19718181A1 (de) * 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel
JP4438919B2 (ja) 1997-10-24 2010-03-24 日産化学工業株式会社 スルファモイル化合物並びに農園芸用殺菌剤
WO1999026612A1 (en) 1997-11-21 1999-06-03 Smithkline Beecham Corporation Novel cannabinoid receptor modulators
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
AU1918299A (en) * 1998-02-23 1999-09-06 Warner-Lambert Company Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
NZ506435A (en) 1998-03-26 2002-08-28 Shionogi & Co 3-Indoly-2-hydroxy-4-oxo-2-butanoic acid useful as antiviral activity
CN1310621A (zh) 1998-07-28 2001-08-29 史密丝克莱恩比彻姆公司 取代的n－酰苯胺化合物和方法
ATE289593T1 (de) * 1999-05-06 2005-03-15 Neurogen Corp Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
EP2014285B1 (en) 1999-11-26 2010-05-05 Shionogi&Co., Ltd. NPYY5 antagonists
EP1242366A1 (en) 1999-12-15 2002-09-25 Axys Pharmaceuticals, Inc. Salicylamides as serine protease and factor xa inhibitors
EP1741713A3 (en) 1999-12-15 2009-09-09 Bristol-Myers Squibb Company Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
ATE311366T1 (de) 2000-02-29 2005-12-15 Millennium Pharm Inc Benzamide und ähnliche inhibitoren vom faktor xa
CA2402414A1 (en) 2000-03-22 2001-09-27 Christopher Bayly Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
US7132567B2 (en) 2000-04-03 2006-11-07 Cerno Biosciences, Llc Generation of combinatorial synthetic libraries and screening for proadhesins and nonadhesins
CN1657523A (zh) 2000-04-28 2005-08-24 田边制药株式会社 环状化合物
AU2001258771A1 (en) 2000-05-19 2001-11-26 Takeda Chemical Industries Ltd. -secretase inhibitors
US7507767B2 (en) 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
US7067539B2 (en) * 2001-02-08 2006-06-27 Schering Corporation Cannabinoid receptor ligands
WO2002090336A1 (de) * 2001-05-09 2002-11-14 Bayer Cropscience Ag Substituierte arylketone
HUP0401924A3 (en) 2001-11-14 2009-07-28 Schering Corp Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them
GB2384313A (en) * 2002-01-18 2003-07-23 Qinetiq Ltd An attitude sensor
AR040126A1 (es) * 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento

Similar Documents

Publication Publication Date Title
JP2005533809A5 (enExample)
CN112752756B (zh) 作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物
US10155765B2 (en) Carboxamide inhibitors of IRAK4 activity
EP3200790B1 (en) Inhibitors of irak4 activity
CN116348477A (zh) 作为抗病毒剂的功能化肽
MXPA04012704A (es) Agonistas de los receptores canabinoides.
JP4764550B2 (ja) 複素環カリウムチャンネル阻害薬
JP2020180145A (ja) 癌並びに免疫疾患及び自己免疫疾患の治療用としてのアポトーシス誘導剤
JP2005533005A5 (enExample)
ES2337241T3 (es) Derivados de piperazina con actividad antagonista de receptores ccr1.
CN101796028A (zh) 1-苯基-2-吡啶基烷醇的衍生物作为磷酸二酯酶抑制剂
US11957687B2 (en) Modulators of HSD17B13 and methods of use thereof
TWI597071B (zh) 包含雷公藤內酯醇衍生物之組合物及其用途
WO2004007472A1 (ja) Ｃｃｒ４アンタゴニストおよびその医薬用途
CN111225665A (zh) 大环免疫调节剂
CN116547294A (zh) 作为抗病毒剂的功能化肽
TW200813033A (en) 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor ligands
JP2010521522A5 (enExample)
JP2013504604A (ja) ウイルスポリメラーゼ阻害剤としてのキナゾリノン誘導体
TW201630866A (zh) 免疫調節藥劑
TWI579277B (zh) 取代桂皮醯胺衍生物、其製備方法、其應用及醫藥組成物
EP2895482B1 (en) Hiv protease inhibitors
CN101061131A (zh) 吉西他滨衍生物纳微粒
CN1939910A (zh) 氨基嘧啶类化合物及其盐和其制备方法与药物用途
JP6462151B2 (ja) グレリンｏ−アシルトランスフェラーゼ阻害剤